Caffeine as an Adjuvant Therapy for Late Preterm Infants With Respiratory Distress

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

October 12, 2023

Primary Completion Date

October 30, 2027

Study Completion Date

January 1, 2028

Conditions
PrematurityRespiratory DiseaseVentilator Lung; Newborn
Interventions
DRUG

Caffeine citrate

Caffeine citrate in loading dose 20 mg/kg (equivalent for 10 mg/kg caffeine base) and maintenance dose 10 mg/kg/day (equivalent for 5 mg/kg caffeine base)

OTHER

Placebo

Equivalent volume of saline

Trial Locations (2)

42319

RECRUITING

King Salman Bin Abdulaziz Medical City, Madinah

Unknown

RECRUITING

King Salman Bin Abdulaziz Medical City, Madinah

All Listed Sponsors
lead

Ministry of Health, Saudi Arabia

OTHER_GOV